Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Elevation Oncology
Universitair Ziekenhuis Brussel
M.D. Anderson Cancer Center
Main Line Health
Bay Area Gynecology Oncology
St. Luke's-Roosevelt Hospital Center